"Knowledge societies rest on a foundation of educational and research excellence. The Internet, advances in communications technology, and the rapidly expanding global fiber optic network are necessary, but not sufficient. It takes people to train, to educate, to collaborate, and to innovate. Building the global knowledge society is the theme of the 2012 American Association for the Advancement of Science (AAAS) Annual Meeting in Vancouver (16 to 22 February). Bringing together scientists and educators from more than 50 nations, the meeting tackles global issues and new ways of building connections between developed and developing nations."
"Google's Richard DeVaul, who goes by the title, Rapid Evaluator (mad scientist) posted on Google+: The “solve for x” conference continues to be really interesting. Today we have had talks on transforming education, 5x improvements in agriculture through better decision support, synthetic biology and carbon-negative biofuels."
Singularity University is partnering with Triple Ring Technologies to mentor and develop select synthetic biology teams between May and August 2012. We are looking for promising biotechnology entrepreneurs who we can help to incorporate and develop products and services that can be made and tested in a short amount of time (three months), and with little capital (on average less than $50k).
Biotechnology is poised to follow this trend because of synthetic biology: genetic engineering done with software-based design tools coupled with DNA synthesis and assembly. While it is still the early days for this field of biological engineering and it is still largely under the radar, the evidence for a paradigm shift in biotechnology is mounting. Using synthetic biology, undergraduate students are developing everything from DNA data storage systems to new biofuels or gene therapies in just months; DIYbio enthusiasts are making DNA testing kits, PCR machines and more; and graduate scientists are bootstrapping innovative synbio companies like Ginkgo Bioworks (custom-made organisms), Geneweave Biosciences (phage-based diagnostics), and Genome Compiler Corporation (genome design software).
We want to see great biotech ideas turn into startup biotech companies. What’s a great idea? A product or service that: Needs more assembly than breakthrough invention (development, not research) Can be advanced to a working demo in 3 months (seeing is believing) Is understandable to general audiences (non-experts) Has identifiable customers and markets Has few or no regulatory barriers Catches people’s attention, usually in a positive way High profit and growth potential Example: Nobel Prizewinner Kary Mullis dreamed up a way to amplify DNA and did proof-of-concept a few months later. The technique he invented, Polymerase Chain Reaction (PCR), revolutionized life science and generated billions in revenue.
What we’re looking for Emerging, passionate bio-entrepreneurs who are ready to work hard and have fun. Completion of a short application that tells us who you are, explains your big idea, and outlines what you need to be successful. If your idea and team are promising, one or more interviews as a next step in the process. If accepted, a detailed summary that will help us help you hit the ground running. Relocation to the SF Bay Area to develop your idea and company between May and August 2012.
The researcher rebellion against the closed research-and-publishing system, tallied most explicitly in a petition boycotting publisher Elsevier, continues to expand. (The Economist covers it here, and I covered the complaints last year in a feature.) The big question, of course, is whether this noisy riot will engender something like a real revolution. Will it replace the old regime with a new?
"Personalized cancer medicine is based on increased knowledge of the cancer mutation repertoire and availability of agents that target altered genes or pathways. Given advances in cancer genetics, technology, and therapeutics development, the timing is right to develop a clinical trial and research framework to move future clinical decisions from heuristic to evidence-based decisions. Although the challenges of integrating genomic testing into cancer treatment decision making are wide-ranging and complex, there is a scientific and ethical imperative to realize the benefits of personalized cancer medicine, given the overwhelming burden of cancer and the unprecedented opportunities for advancements in outcomes for patients."
Today I had an awesome conversation with David Stavens Co-Founder and CEO of UDACITY. This is really a great project, which deserves your support. UDACITY provides free University courses at the present in computer science and rewrite, who a University is done. I recommend to have a look to their web page.
UDACITY connected the greatest teachers to thousands of students all over the world - free courses
"We believe university-level education can be both high quality and low cost. Using the economics of the Internet, we've connected some of the greatest teachers to hundreds of thousands of students in almost every country on Earth. Udacity was founded by three roboticists who believed much of the educational value of their university classes could be offered online for very low cost. A few weeks later, over 160,000 students in more than 190 countries enrolled in our first class, "Introduction to Artificial Intelligence." The class was twice profiled by the New York Times and also by other news media. Now we're a growing team of educators and engineers, on a mission to change the future of education."
CS 101: BUILDING A SEARCH ENGINE Taught by Professor David Evans (Professor of Computer Science at the University of Virginia) and Professor Sebastian Thrun (Professor of Computer Science at Stanford University, a Google Fellow)
CS 373: PROGRAMMING A ROBOTIC CAR Taught by Professor Sebastian Thrun
"At long last, researchers may be able to sequence the genomes of any microbe, even ones they can't grow in the lab.
Until now, researchers had just two main ways to sequence their genomes. They could sequence the genome directly, but that required growing the organism in culture to a manageable level, and that has not been possible for most microbes. Alternatively, they could use a technique known as metagenomics, and try to pick out DNA that belongs to the microbe from the vast amount of genetic material present in an environmental sample. That method, however, works only if the organism is the dominant member of a simple community or if it or a close relative has had its genome sequenced before that could serve as a blueprint."
"Auxin is a key plant morphogenetic signal but tools to analyse dynamically its distribution and signalling during development are still limited. Auxin perception directly triggers the degradation of Aux/IAA repressor proteins. Here we describe a novel Aux/IAA-based auxin signalling sensor termed DII-VENUS that was engineered in the model plant Arabidopsis thaliana. The VENUS fast maturing form of yellow fluorescent protein was fused in-frame to the Aux/IAA auxin-interaction domain (termed domain II; DII) and expressed under a constitutive promoter. We initially show that DII-VENUS abundance is dependent on auxin, its TIR1/AFBs co-receptors and proteasome activities. Next, we demonstrate that DII-VENUS provides a map of relative auxin distribution at cellular resolution in different tissues. DII-VENUS is also rapidly degraded in response to auxin and we used it to visualize dynamic changes in cellular auxin distribution successfully during two developmental responses, the root gravitropic response and lateral organ production at the shoot apex. Our results illustrate the value of developing response input sensors such as DII-VENUS to provide high-resolution spatio-temporal information about hormone distribution and response during plant growth and development."
This guest post was written by Richard Price, founder and CEO of Academia.edu — a site that serves as a platform for academics to share their research papers and to interact with each other.
New TED Book – Living Architecture – Releases 7 FebruaryGreen Building ElementsRachel Armstrong is the co-director of AVATAR (Advanced Virtual and Technological Architectural Research) specializing in Architecture and Synthetic Biology at the...
Synbiota is building a bio-lab in a browser. Synthetic Biology promises to revolutionize the world in ways we have yet to imagine. Synbiota is working towards this revolution by developing powerful, standards-based, open and free tools for synthetic biology design. We need your help! We are currently in the very early stages of development and are actively recruiting those who can help us. We are an international multidisciplinary team and we seek individuals with a wide variety of skills to join the effort.
HTML5 developers with vision Backend developers with chutzpah User Interface Designers with big hearts for users Synthetic Biologists (Professional, Student, DIY) Artists with big imaginations Information Designers with a hankering for Big Data Administrators with international dreams Are you what we are looking for? Contact us at: join@synbiota.com
Stay connected with Synbiota and get updated about our progress. Join our spam-free mailing list, and don't forget to add @Synbiota on Twitter!
"Ecosystems are shaped by complex communities of mostly unculturable microbes. Metagenomes provide a fragmented view of such communities, but the ecosystem functions of major groups of organisms remain mysterious. To better characterize members of these communities, we developed methods to reconstruct genomes directly from mate-paired short-read metagenomes. We closed a genome representing the as-yet uncultured marine group II Euryarchaeota, assembled de novo from 1.7% of a metagenome sequenced from surface seawater. The genome describes a motile, photo-heterotrophic cell focused on degradation of protein and lipids and clarifies the origin of proteorhodopsin. It also demonstrates that high-coverage mate-paired sequence can overcome assembly difficulties caused by interstrain variation in complex microbial communities, enabling inference of ecosystem functions for uncultured members."
"Yeast species such as Saccharomyces cerevisiae have been exploited by humans for millennia and so it is therefore unsurprising that they are attractive cells to re-engineer for industrial use. Despite many beneficial traits yeast has for synthetic biology, it currently lags behind Escherichia coli in the number of synthetic networks that have been described. While the eukaryotic nature of yeast means that its regulation is not as simple to predict as it is for E. coli, once initial considerations have been made yeast is pleasingly tractable. In this review we provide a loose guide for constructing and implementing synthetic regulatory networks in S. cerevisiae using examples from previous research to highlight available resources, specific considerations and potential future advances."
"Synthetic Biology is in a critical phase of its development: it has finally reached the point where it can move from proof-of-principle studies to real-world applications. Secondary metabolite biosynthesis, especially the discovery and production of antibiotics, is a particularly relevant target area for such applications of synthetic biology. The first international conference to explore this subject was held in Spain in October 2011. In four sessions on General Synthetic Biology, Filamentous Fungal Systems, Actinomyces Systems, and Tools and Host Structures, scientists presented the most recent technological and scientific advances, and a final-day Forward Look Plenary Discussion identified future trends in the field."
"Protein pathways are dynamic and highly coordinated spatially and temporally, capable of performing a diverse range of complex chemistries and enzymatic reactions with precision and at high efficiency. Biotechnology aims to harvest these natural systems to construct more advanced in vitro reactions, capable of new chemistries and operating at high yield. Here, we present an efficient Multiplex Automated Genome Engineering (MAGE) strategy to simultaneously modify and co-purify large protein complexes and pathways from the model organism Escherichia coli to reconstitute functional synthetic proteomes in vitro. By application of over 110 MAGE cycles, we successfully inserted hexa-histidine sequences into 38 essential genes in vivo that encode for the entire translation machinery. Streamlined co-purification and reconstitution of the translation protein complex enabled protein synthesis in vitro. Our approach can be applied to a growing area of applications in in vitro one-pot multi-enzyme catalysis (MEC) to manipulate or enhance in vitro pathways such as natural product or carbohydrate biosynthesis."
To get content containing either thought or leadership enter:
To get content containing both thought and leadership enter:
To get content containing the expression thought leadership enter:
You can enter several keywords and you can refine them whenever you want. Our suggestion engine uses more signals but entering a few keywords here will rapidly give you great content to curate.